Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Daniel Levangie Insider Profile
4 Followers
Daniel Levangie, President, Drug Delivery at Insulet, holds 10.66K shares in Insulet (Ticker: PODD), holds ― shares in Renalytix AI (Ticker: RNLX), holds 22.98K shares in Exact Sciences (Ticker: EXAS).
Daniel Levangie has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Daniel Levangie holds in companies
Most Profitable Insider Trade
The most profitable trade made by Daniel Levangie
Daniel Levangie's Trading History
Insulet
May 02, 2016
President, Drug Delivery
Uninformative Sell
21.71K
$1.77M
Renalytix AI
―
Director
―
―
Exact Sciences
Mar 04, 2024
Director
Uninformative Sell
287.50K
$1.35M
LipoScience
Nov 24, 2014
―
Uninformative Sell
105.40K
―
Hologic
―
Director
―
$19.45K
List of latest transactions for each holding click on a transaction to see Daniel Levangie's performance on stock
You May Also Like
Daniel Levangie insider profile FAQ
What is the percentage of profitable transactions made by Daniel Levangie?
The percentage of profitable transactions made by Daniel Levangie is ―.
What is the average return per transaction made by Daniel Levangie?
The average return per transaction made by Daniel Levangie is ―.
What stocks does Daniel Levangie hold?
Daniel Levangie holds: PODD, RNLX, EXAS, LPDX, HOLX stocks.
What was Daniel Levangie’s latest transaction?
Daniel Levangie latest transaction was an Uninformative Sell of $21.71K.
What was Daniel Levangie's most profitable transaction?
Daniel Levangie’s most profitable transaction was an Informative Sell of PODD stock on March 9, 2016. The return on the trade was -45.70%.
What is Daniel Levangie's role in Insulet?
Daniel Levangie's role in Insulet is President, Drug Delivery.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.